Using eHealth to Increase the Reach of Evidence-based Treatments for PTSD: Lessons Learned from the Web-PE Studies
featuring Dr. Carmen McLean, PhD
Although several evidence-based psychotherapies (EBPs) for posttraumatic stress disorder (PTSD) exist, logistical and stigma-related barriers often deter individuals with PTSD from accessing these treatments. Even when care is sought, PTSD patients rarely receive EBPs, because organizational and attitudinal barriers deter PTSD providers from using EBPs. Thus, improved accessibility of EBPs for individuals with PTSD is urgently needed to meet the demand for timely care. E-Health treatments represent an innovative way to greatly increase the reach of EBPs for PTSD. The efficacy of eHealth treatments for PTSD is promising, though many important questions remain, including: Can face-to-face EBPs be delivered effectively online? How much human support is needed to ensure engagement? For whom are eHealth interventions best suited?
This webinar addresses these questions in the context of Dr. McLean’s research on eHealth for PTSD. Specifically, Dr. McLean will describe two recent studies evaluating the efficacy of a web-version of Prolonged Exposure (PE), “Web-PE,” among active-duty military personnel and veterans with PTSD. The first study was a small randomized controlled trial of Web-PE compared to face-to-face present centered therapy at Fort Hood, TX, and the second was an open trial of Web-PE, where participants were recruited nationally. The preliminary results of these studies, including both quantitative and qualitative data, as well as the lessons learned, will be presented. Current and future research, including studies examining a web-version of written exposure therapy and a self-guided exposure therapy mobile app will also be described.
Learning Objectives:
- Describe at least two advantages to eHealth interventions over traditional face-to-face care.
- Explain how Web-PE differs from prior eHealth interventions for PTSD.
- List at least one reason why the efficacy of Web-PE likely differed across the two trials.
This webinar is eligible for CE. Read more information on CE/CME here: https://adaa.org/education/ce-credits